British Columbia Centre on Substance Use, 1045 Howe St Suite 400, Vancouver, British Columbia, V6Z 2A9, Canada.
Department of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, British Columbia, V6T 1Z3, Canada.
J Urban Health. 2021 Feb;98(1):59-69. doi: 10.1007/s11524-020-00489-9. Epub 2020 Oct 28.
North America is experiencing an overdose crisis driven by fentanyl, related analogues, and fentanyl-adulterated drugs. In response, there have been increased calls for "safe supply" interventions based on the premise that providing a safer alternative (i.e., pharmaceutical drugs of known quality/quantity, non-adulterated, with user agency in consumption methods) to the street drug supply will limit people's use of fentanyl-adulterated drugs and reduce overdose events. This study examined outcomes of a hydromorphone tablet distribution program intended to prevent overdose events among people who use drugs (PWUD) at high risk of fatal overdose. Semi-structured qualitative interviews were conducted with 42 people enrolled in the hydromorphone distribution program. Additionally, over 100 h of ethnographic observation were undertaken in and around the study site. Transcripts were coded using NVivo and based on categories extracted from the interview guides and those identified during initial interviews and ethnographic fieldwork. Analysis focused on narratives around experiences with the program, focusing on program-related outcomes. Our analysis identified the following positive outcomes of being enrolled in the hydromorphone tablet distribution program: (1) reduced street drug use and overdose risk, (2) improvements to health and well-being, (3) improvements in co-management of pain, and (4) economic improvements. Our findings indicate that the hydromorphone distribution program not only is effective in responding to the current overdose crisis by reducing people's use of illicit drugs but also addresses inequities stemming from the intersection of drug use and social inequality. Safe supply programs should be further implemented and evaluated in both urban and rural setting across North America as a strategy to reduce exposure to the toxic drug supply and fatal overdose.
北美洲正经历一场由芬太尼、相关类似物和芬太尼掺杂物导致的阿片类药物过量危机。有鉴于此,人们越来越多地呼吁采取“安全供应”干预措施,其前提是为街头毒品供应提供更安全的替代品(即质量/数量已知的药物、未掺假、使用者可自主选择消费方式),以限制人们对芬太尼掺杂物的使用并减少过量用药事件。本研究调查了一项氢吗啡酮片剂分发计划的结果,该计划旨在预防高危致命过量用药的药物使用障碍者(PWUD)发生过量用药事件。对 42 名参加氢吗啡酮分发计划的人员进行了半结构式定性访谈。此外,还在研究现场及周边进行了超过 100 小时的民族志观察。使用 NVivo 对转录本进行编码,并根据访谈指南中提取的类别以及在最初访谈和民族志实地工作中确定的类别进行编码。分析重点是围绕该计划的经历的叙述,重点关注与该计划相关的结果。我们的分析确定了参加氢吗啡酮片剂分发计划的以下积极结果:(1)减少街头毒品使用和过量用药风险;(2)改善健康和福祉;(3)改善疼痛的共同管理;(4)经济改善。我们的研究结果表明,该氢吗啡酮分发计划不仅通过减少人们对非法药物的使用有效应对当前的过量用药危机,而且还解决了药物使用和社会不平等相互交织所产生的不平等问题。安全供应计划应在北美城乡地区进一步实施和评估,作为减少接触有毒毒品供应和致命过量用药的策略。